Completion of subscription of N-series shares issued in connection with the Company's employee incentive programme

Current Report No. 18/2023

Date of preparation: 11 May 2023

Subject: Completion of subscription of N-series shares issued in connection with the Company's employee incentive programme

Legal basis: Art. 56(1)(2) of the Public Offering Act - current and periodic information

The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs the completion of the subscription of the Company's N-series shares (the "Shares") issued pursuant to Board Resolution No. 2 of 14 February 2023.

The issue of Shares was carried out by private subscription. Share subscription agreements were concluded with eligible persons as part of the Company's employee incentive programme.

1. start and end date of subscription.

Subscription commencement date: 14 February 2023 (date of the resolution of the Board of Directors of the Company on the issue of Shares).

Subscription closing date: 27 April 2023 (date of the last Share subscription agreement).

2. Date of allotment of Shares.

Not applicable. The Shares were taken up by way of a private placement and therefore no shares were allotted within the meaning of the Companies Act. All Share subscription agreements have been concluded until 27 April 2023.

3. Number of Shares subscribed for.

11,292 N-series ordinary bearer shares with a nominal value of PLN 0.10 (ten cents) each were subscribed.

4 Rate of reduction in individual tranches in the event that in at least one tranche the number of allotted Shares was less than the number of Shares subscribed for.

Not applicable. Due to the type of subscription, no reduction occurred. The Shares were subscribed for privately and therefore no Shares were subscribed for. All persons who were offered to conclude Share subscription agreements concluded such agreements with the Company.

5. the number of Shares subscribed for.

Subscription agreements covering a total of 11,292 Shares were concluded.

6. the number of Shares allotted in the subscription.

Not applicable (as indicated in point 2 above, no Shares were allotted). Under the Share Subscription Agreements, 11,292 Shares were subscribed for.

7 The price at which the Shares were taken up.

Shares were subscribed for at a price of PLN 0.10 (ten cents) per Share.

8 The number of persons who subscribed for the Shares subscribed for in each tranche.

Share subscription agreements were concluded with 9 individuals.

9. the number of persons to whom Shares were allotted in the subscription of each tranche.

No shares were allotted. Share subscription agreements were concluded with 9 individuals.

10 The name(s) of the underwriters who have subscribed for the Shares in the performance of the underwriting agreements, specifying the number of securities which they have subscribed for, together with the actual price per unit of the security, being the issue or sale price, after deduction of the consideration for subscribing for the Shares, in the performance of the underwriting agreement, acquired by the underwriter.

Not applicable, the Company has not entered into an underwriting agreement.

11. the value of the subscription made, understood as the product of the number and the issue price.

PLN 1,129.20 (one thousand one hundred and twenty-nine zlotys 20/100).

12 The amount of the total costs which have been included in the costs of issue, indicating the amount of costs by title.

The Company did not incur costs included in the issue costs such as the costs of preparing and conducting the offer, underwriters' remuneration, preparing the prospectus or other offering document or promoting the offer.

13 The average cost of carrying out the subscription per unit of security subscribed or sold.

As indicated above, the Company has not incurred the costs of issuing the Shares referred to above and therefore there is no average cost per Share to subscribe for the Shares.

14 The manner in which the securities acquired have been paid up, with details where the acquisition has been effected by means of set-off of claims and where the acquisition has been effected for non-cash contributions.

The shares were paid for in cash by payment of funds into the Company's bank account.